+28.2%
MRNA vs CFG
+182.2%
-154.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CFG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.9% | -2.5% | -3.1% |
| 7D | -10.1% | -0.6% | -9.5% | -9.9% |
| 30D | +126.7% | -4.5% | +131.3% | +127.9% |
| 3M | +184.1% | +6.3% | +177.8% | +169.1% |
| 6M | +143.3% | +20.6% | +122.7% | +115.3% |
| YTD | +359.9% | +21.2% | +338.6% | +305.5% |
| 1Y | +454.2% | +38.2% | +416.0% | +357.0% |
| All | +28.2% | +182.2% | -154.0% | -24.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CFG.
Daily Out/Under-Performance
Portfolio return minus CFG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CFG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CFG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling